ORLANDO, Fla. — The United States Food and Drug Administration is expected to make a key announcement this week on a possible treatment for dementia.
>>> STREAM CHANNEL 9 EYEWITNESS NEWS LIVE <<<
The experimental drug Lecanemab is up for accelerated approval.
Read: FDA fast-tracks review of overdose-reversal drug for use without prescription
Trials indicate the drug has shown “potential” as an Alzheimer’s disease treatment, but there are safety concerns.
Read: FDA changes Plan B label, clarifies it won’t cause abortion
It’s been associated with certain serious adverse events, including brain swelling and bleeding.
Read: Probe: Alzheimer’s drug approval ‘rife with irregularities’
The FDA’s final decision is expected by Friday.
Click here to download the free WFTV news and weather apps, click here to download the WFTV Now app for your smart TV and click here to stream Channel 9 Eyewitness News live.
©2023 Cox Media Group
